October 30 – November 2 2023 | Boston, MA

This Fall, the world’s longest-standing and most comprehensive TPD meeting, the 6th Targeted Protein Degradation Summit, returns to Boston in 2023 as the trusted, definitive, end-to-end forum for the global network of protein degradation drug developers.

Join over 100 world-class TPD experts alongside a further 600 of your peers as the community assembles to hear breaking clinical updates and outstanding new innovations, and problem-solve unifying challenges.

Beacon’s Lead TPD Research Analyst, Katie Spooner, will be exploring the Clinical & Preclinical Activity of Novel Bifunctional Degraders Across the TPD Field, on Conference Day 1, as part of the Clinical Development track, at 5:10 pm; this is not one to be missed with some exclusive insights from the Beacon database!

Across 4 days, 4 tracks of content are split based on the stage of drug development: target ID, lead optimization, preclinical, and clinical. Choose the track that your expertise is best suited to. With a brand-new pre-conference day dedicated to TPD in CNS, revamped workshops, and the KOL Future Advisory Panel, this is the most all-encompassing TPD event yet.